VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PMVP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PMVPPMV Pharmaceuticals, Inc.
$1.24$66M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPMVPQuarterly Financials

PMV Pharmaceuticals, Inc. (PMVP) Quarterly Financials

120+ quarters historyFree accessUpdated daily

PMV Pharmaceuticals, Inc. (PMVP) quarterly income statement — complete revenue, gross profit & net income history

PMVP Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold34K0032K000372K362K359K0000000000
COGS % of Revenue--------------------
Gross Profit-34K00-32K000-372K-362K-359K0000000000
Gross Margin %--------------------
Gross Profit Growth %---91.4%100%100%--------------
Operating Expenses18.98M19.24M22.52M22.85M21.56M25.17M21.89M19.8M17.86M18.54M19.63M20.12M21.48M21.16M19.38M17.89M18.62M18.47M15.1M13.05M
OpEx % of Revenue--------------------
Selling, General & Admin3.69M3.42M4.31M4.48M4.12M11.4M4.94M5.54M5.04M5.52M6.04M6.28M6.41M6.14M5.71M6.42M6.78M6.3M5.93M5.39M
SG&A % of Revenue--------------------
Research & Development15.3M15.83M18.21M18.37M17.44M13.77M16.95M14.26M12.82M13.02M13.59M13.84M15.07M15.03M13.67M11.46M11.84M12.17M9.16M7.66M
R&D % of Revenue--------------------
Other Operating Expenses0000000-17K-1K00000000000
Operating Income-19.02M-19.24M-22.52M-22.88M-21.56M-25.17M-21.89M-20.17M-18.22M-18.9M-19.63M-20.12M-21.48M-21.16M-19.38M-17.89M-18.62M-18.47M-15.1M-13.05M
Operating Margin %--------------------
Operating Income Growth %11.8%23.55%-2.9%-13.43%-18.35%-33.15%-11.51%-0.24%15.17%10.68%-1.31%-12.51%-15.37%-14.56%-28.34%-37.05%-59.49%-75.91%-73.51%-61.41%
EBITDA-18.98M-19.21M-22.49M-22.85M-21.53M-25.13M-21.52M-19.8M-17.86M-18.54M-19.27M-19.75M-21.31M-21.09M-19.3M-17.8M-18.54M-18.39M-15.02M-12.98M
EBITDA Margin %--------------------
EBITDA Growth %11.81%23.56%-4.53%-15.4%-20.54%-35.52%-11.66%-0.23%16.19%12.06%0.16%-10.95%-14.97%-14.63%-28.53%-37.17%-59.85%-76.2%-74.09%-62.3%
D&A (Non-Cash Add-back)34K33K31K32K37K39K371K372K362K359K358K369K171K75K74K82K84K77K80K71K
EBIT-19.02M-19.24M-22.52M-21.2M-21.56M-25.17M-21.89M-20.17M-18.22M-15.76M-19.63M-20.12M-21.48M-21.16M-19.38M-17.89M-18.62M-18.47M-15.1M-13.05M
Net Interest Income980K1.23M1.48M1.69M1.94M2.29M2.62M2.8M2.95M3.17M2.98M2.7M2.33M1.8M1.12M604K229K106K102K113K
Interest Income980K1.23M1.48M1.69M1.94M2.29M2.62M2.8M2.95M3.17M2.98M2.7M2.33M1.8M1.12M604K229K106K102K113K
Interest Expense00000000000000000000
Other Income/Expense981K1.23M1.46M1.67M1.93M2.17M2.74M2.78M2.95M3.15M2.99M2.69M2.35M1.82M1.14M573K188K113K105K176K
Pretax Income-18.04M-18.01M-21.07M-21.2M-19.63M-23M-19.15M-17.39M-15.27M-15.76M-16.64M-17.43M-19.13M-19.34M-18.24M-17.31M-18.43M-18.36M-14.99M-12.87M
Pretax Margin %--------------------
Income Tax026K-6K5K-2.2M074K-16.17M0-1K04K00-9K-2K2K019K0
Effective Tax Rate %0%-0.14%0.03%-0.02%11.19%0%-0.39%93.02%0%0.01%0%-0.02%0%0%0.05%0.01%-0.01%0%-0.13%0%
Net Income-18.04M-18.04M-21.06M-21.21M-17.44M-23M-19.23M-1.21M-15.27M-15.76M-16.64M-17.44M-19.13M-19.34M-18.23M-17.31M-18.43M-18.36M-15.01M-12.87M
Net Margin %--------------------
Net Income Growth %-3.45%21.58%-9.53%-1648.56%-14.18%-45.98%-15.54%93.04%20.17%18.55%8.72%-0.73%-3.77%-5.37%-21.44%-34.46%-58.88%-75.62%-71.28%-61.59%
Net Income (Continuing)-18.04M-18.04M-21.06M-21.21M-17.44M-23M-19.23M-1.21M-15.27M-15.76M-16.64M-17.44M-19.13M-19.34M-18.23M-17.31M-18.43M-18.36M-15.01M-12.87M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.34-0.34-0.40-0.41-0.340.37-0.37-0.02-0.30-0.31-0.34-0.38-0.42-0.42-0.40-0.38-0.41-0.41-0.33-0.29
EPS Growth %0%-191.89%-8.11%-1950%-13.33%220.81%-8.82%94.74%28.57%27.65%15%0%-2.44%-4.43%-21.21%-31.03%-57.69%-44.76%-43.48%-52.63%
EPS (Basic)-0.34-0.34-0.40-0.41-0.340.37-0.37-0.02-0.30-0.31-0.34-0.38-0.42-0.42-0.40-0.38-0.41-0.41-0.33-0.29
Diluted Shares Outstanding53.33M53.28M52.99M52.01M51.95M51.57M51.57M51.48M51.45M51.45M49.05M45.81M45.77M45.7M45.62M45.57M45.47M45.3M45.3M45.07M
Basic Shares Outstanding53.33M53.28M52.99M52.01M51.95M51.57M51.57M51.48M51.45M51.45M49.05M45.81M45.77M45.7M45.62M45.57M45.47M45.3M45.3M45.07M
Dividend Payout Ratio--------------------